Logo image of MCHPP

MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MCHPP - US5950173022

65.59 USD
-1.05 (-1.58%)
Last: 1/8/2026, 1:26:41 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MCHPP. MCHPP was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. MCHPP has only an average score on both its financial health and profitability. MCHPP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MCHPP had positive earnings in the past year.
In the past year MCHPP had a positive cash flow from operations.
MCHPP had positive earnings in 4 of the past 5 years.
MCHPP had a positive operating cash flow in each of the past 5 years.
MCHPP Yearly Net Income VS EBIT VS OCF VS FCFMCHPP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of -1.69%, MCHPP is in line with its industry, outperforming 42.48% of the companies in the same industry.
With a Return On Equity value of -3.66%, MCHPP perfoms like the industry average, outperforming 41.59% of the companies in the same industry.
MCHPP's Return On Invested Capital of 0.91% is in line compared to the rest of the industry. MCHPP outperforms 50.44% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MCHPP is in line with the industry average of 10.75%.
The 3 year average ROIC (11.93%) for MCHPP is well above the current ROIC(0.91%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.69%
ROE -3.66%
ROIC 0.91%
ROA(3y)8.56%
ROA(5y)7.14%
ROE(3y)20.99%
ROE(5y)18.26%
ROIC(3y)11.93%
ROIC(5y)10.28%
MCHPP Yearly ROA, ROE, ROICMCHPP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

MCHPP has a Operating Margin (3.68%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of MCHPP has declined.
MCHPP has a Gross Margin of 54.06%. This is in the better half of the industry: MCHPP outperforms 71.68% of its industry peers.
In the last couple of years the Gross Margin of MCHPP has declined.
Industry RankSector Rank
OM 3.68%
PM (TTM) N/A
GM 54.06%
OM growth 3Y-32.35%
OM growth 5Y-8.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.92%
GM growth 5Y-1.82%
MCHPP Yearly Profit, Operating, Gross MarginsMCHPP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MCHPP is creating some value.
The number of shares outstanding for MCHPP has been increased compared to 1 year ago.
The number of shares outstanding for MCHPP has been increased compared to 5 years ago.
The debt/assets ratio for MCHPP has been reduced compared to a year ago.
MCHPP Yearly Shares OutstandingMCHPP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
MCHPP Yearly Total Debt VS Total AssetsMCHPP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

An Altman-Z score of 3.72 indicates that MCHPP is not in any danger for bankruptcy at the moment.
With a Altman-Z score value of 3.72, MCHPP perfoms like the industry average, outperforming 49.56% of the companies in the same industry.
MCHPP has a debt to FCF ratio of 7.13. This is a slightly negative value and a sign of low solvency as MCHPP would need 7.13 years to pay back of all of its debts.
MCHPP has a Debt to FCF ratio (7.13) which is in line with its industry peers.
MCHPP has a Debt/Equity ratio of 0.80. This is a neutral value indicating MCHPP is somewhat dependend on debt financing.
MCHPP has a Debt to Equity ratio of 0.80. This is in the lower half of the industry: MCHPP underperforms 79.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 7.13
Altman-Z 3.72
ROIC/WACC0.09
WACC10.56%
MCHPP Yearly LT Debt VS Equity VS FCFMCHPP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 2.25 indicates that MCHPP has no problem at all paying its short term obligations.
MCHPP has a Current ratio of 2.25. This is in the lower half of the industry: MCHPP underperforms 68.14% of its industry peers.
A Quick Ratio of 1.20 indicates that MCHPP should not have too much problems paying its short term obligations.
MCHPP has a worse Quick ratio (1.20) than 80.53% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.2
MCHPP Yearly Current Assets VS Current LiabilitesMCHPP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

4

3. Growth

3.1 Past

MCHPP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -64.77%.
MCHPP shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.29% yearly.
Looking at the last year, MCHPP shows a very negative growth in Revenue. The Revenue has decreased by -23.36% in the last year.
MCHPP shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.55% yearly.
EPS 1Y (TTM)-64.77%
EPS 3Y-34.42%
EPS 5Y-14.29%
EPS Q2Q%-23.91%
Revenue 1Y (TTM)-23.36%
Revenue growth 3Y-13.58%
Revenue growth 5Y-3.55%
Sales Q2Q%-2.01%

3.2 Future

Based on estimates for the next years, MCHPP will show a very strong growth in Earnings Per Share. The EPS will grow by 29.55% on average per year.
Based on estimates for the next years, MCHPP will show a quite strong growth in Revenue. The Revenue will grow by 9.85% on average per year.
EPS Next Y13.37%
EPS Next 2Y40.15%
EPS Next 3Y41.57%
EPS Next 5Y29.55%
Revenue Next Year3.61%
Revenue Next 2Y11.6%
Revenue Next 3Y13.88%
Revenue Next 5Y9.85%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MCHPP Yearly Revenue VS EstimatesMCHPP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
MCHPP Yearly EPS VS EstimatesMCHPP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 70.53, which means the current valuation is very expensive for MCHPP.
Compared to the rest of the industry, the Price/Earnings ratio of MCHPP is on the same level as its industry peers.
When comparing the Price/Earnings ratio of MCHPP to the average of the S&P500 Index (26.92), we can say MCHPP is valued expensively.
MCHPP is valuated quite expensively with a Price/Forward Earnings ratio of 25.69.
Based on the Price/Forward Earnings ratio, MCHPP is valued a bit cheaper than 74.34% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MCHPP to the average of the S&P500 Index (23.57), we can say MCHPP is valued inline with the index average.
Industry RankSector Rank
PE 70.53
Fwd PE 25.69
MCHPP Price Earnings VS Forward Price EarningsMCHPP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MCHPP.
Based on the Price/Free Cash Flow ratio, MCHPP is valued a bit cheaper than the industry average as 69.91% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 46.99
EV/EBITDA 47.15
MCHPP Per share dataMCHPP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as MCHPP's earnings are expected to grow with 41.57% in the coming years.
PEG (NY)5.28
PEG (5Y)N/A
EPS Next 2Y40.15%
EPS Next 3Y41.57%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.86%, MCHPP has a reasonable but not impressive dividend return.
MCHPP's Dividend Yield is rather good when compared to the industry average which is at 0.57. MCHPP pays more dividend than 93.81% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, MCHPP pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.86%

5.2 History

The dividend of MCHPP is nicely growing with an annual growth rate of 20.15%!
MCHPP does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)20.15%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of MCHPP are negative and hence is the payout ratio. MCHPP will probably not be able to sustain this dividend level.
The dividend of MCHPP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-421.71%
EPS Next 2Y40.15%
EPS Next 3Y41.57%
MCHPP Yearly Income VS Free CF VS DividendMCHPP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28

NASDAQ:MCHPP (1/8/2026, 1:26:41 PM)

65.59

-1.05 (-1.58%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)01-29 2026-01-29/amc
Inst Owners98.58%
Inst Owner ChangeN/A
Ins Owners1.93%
Ins Owner ChangeN/A
Market Cap35.45B
Revenue(TTM)4.21B
Net Income(TTM)-245.10M
Analysts79.39
Price Target70.11 (6.89%)
Short Float %0.17%
Short Ratio6.76
Dividend
Industry RankSector Rank
Dividend Yield 2.86%
Yearly Dividend1.81
Dividend Growth(5Y)20.15%
DP-421.71%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.19%
Min EPS beat(2)2.58%
Max EPS beat(2)11.8%
EPS beat(4)3
Avg EPS beat(4)-2.68%
Min EPS beat(4)-27.71%
Max EPS beat(4)11.8%
EPS beat(8)5
Avg EPS beat(8)-0.82%
EPS beat(12)5
Avg EPS beat(12)-1.03%
EPS beat(16)7
Avg EPS beat(16)-0.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.83%
Min Revenue beat(2)-1.6%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.89%
Min Revenue beat(4)-4.74%
Max Revenue beat(4)-0.05%
Revenue beat(8)0
Avg Revenue beat(8)-1.9%
Revenue beat(12)0
Avg Revenue beat(12)-1.88%
Revenue beat(16)0
Avg Revenue beat(16)-1.69%
PT rev (1m)-2.51%
PT rev (3m)-1.72%
EPS NQ rev (1m)3.71%
EPS NQ rev (3m)-1.29%
EPS NY rev (1m)0.52%
EPS NY rev (3m)-2.79%
Revenue NQ rev (1m)1.12%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)0.39%
Revenue NY rev (3m)-1.73%
Valuation
Industry RankSector Rank
PE 70.53
Fwd PE 25.69
P/S 8.42
P/FCF 46.99
P/OCF 42.14
P/B 5.29
P/tB N/A
EV/EBITDA 47.15
EPS(TTM)0.93
EY1.42%
EPS(NY)2.55
Fwd EY3.89%
FCF(TTM)1.4
FCFY2.13%
OCF(TTM)1.56
OCFY2.37%
SpS7.79
BVpS12.39
TBVpS-4.01
PEG (NY)5.28
PEG (5Y)N/A
Graham Number16.1
Profitability
Industry RankSector Rank
ROA -1.69%
ROE -3.66%
ROCE 1.16%
ROIC 0.91%
ROICexc 0.93%
ROICexgc 2.84%
OM 3.68%
PM (TTM) N/A
GM 54.06%
FCFM 17.91%
ROA(3y)8.56%
ROA(5y)7.14%
ROE(3y)20.99%
ROE(5y)18.26%
ROIC(3y)11.93%
ROIC(5y)10.28%
ROICexc(3y)12.2%
ROICexc(5y)10.52%
ROICexgc(3y)48.65%
ROICexgc(5y)43.88%
ROCE(3y)15.1%
ROCE(5y)13.02%
ROICexgc growth 3Y-44.39%
ROICexgc growth 5Y-17.88%
ROICexc growth 3Y-40.07%
ROICexc growth 5Y-9.14%
OM growth 3Y-32.35%
OM growth 5Y-8.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.92%
GM growth 5Y-1.82%
F-Score3
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 7.13
Debt/EBITDA 6.16
Cap/Depr 12.08%
Cap/Sales 2.06%
Interest Coverage 250
Cash Conversion 96.37%
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 1.2
Altman-Z 3.72
F-Score3
WACC10.56%
ROIC/WACC0.09
Cap/Depr(3y)32.64%
Cap/Depr(5y)27.66%
Cap/Sales(3y)4.12%
Cap/Sales(5y)3.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.77%
EPS 3Y-34.42%
EPS 5Y-14.29%
EPS Q2Q%-23.91%
EPS Next Y13.37%
EPS Next 2Y40.15%
EPS Next 3Y41.57%
EPS Next 5Y29.55%
Revenue 1Y (TTM)-23.36%
Revenue growth 3Y-13.58%
Revenue growth 5Y-3.55%
Sales Q2Q%-2.01%
Revenue Next Year3.61%
Revenue Next 2Y11.6%
Revenue Next 3Y13.88%
Revenue Next 5Y9.85%
EBIT growth 1Y-86.35%
EBIT growth 3Y-41.54%
EBIT growth 5Y-11.55%
EBIT Next Year54.68%
EBIT Next 3Y41.71%
EBIT Next 5Y25.08%
FCF growth 1Y-76.11%
FCF growth 3Y-32.16%
FCF growth 5Y-12.16%
OCF growth 1Y-76.62%
OCF growth 3Y-31.89%
OCF growth 5Y-10.27%

MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 / MCHPP FAQ

Can you provide the ChartMill fundamental rating for MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28?

ChartMill assigns a fundamental rating of 4 / 10 to MCHPP.


Can you provide the valuation status for MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28?

ChartMill assigns a valuation rating of 3 / 10 to MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP). This can be considered as Overvalued.


How profitable is MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) stock?

MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) has a profitability rating of 4 / 10.


What is the earnings growth outlook for MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28?

The Earnings per Share (EPS) of MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) is expected to grow by 13.37% in the next year.


Can you provide the dividend sustainability for MCHPP stock?

The dividend rating of MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) is 4 / 10 and the dividend payout ratio is -421.71%.